Mirum Pharmaceuticals MIRM reported its Q1 earnings results on Thursday, May 4, 2023 at 04:02 PM.
Here's what investors need to know about the announcement.
Earnings
Mirum Pharmaceuticals beat estimated earnings by 14.89%, reporting an EPS of $-0.8 versus an estimate of $-0.94.
Revenue was up $18.71 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 1.01% drop in the share price the next day.
Here's a look at Mirum Pharmaceuticals's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -1.02 | -1.07 | -1.15 | -1.34 |
EPS Actual | -0.99 | -1.02 | -0.84 | -1.17 |
Revenue Estimate | 24.57M | 20.81M | 15.42M | 8.46M |
Revenue Actual | 27.91M | 18.78M | 17.48M | 12.89M |
To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.